209 related articles for article (PubMed ID: 32344890)
41.
Prendergast KA; Nagalingam G; West NP; Triccas JA
Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250863
[TBL] [Abstract][Full Text] [Related]
42. Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.
Hansen SG; Zak DE; Xu G; Ford JC; Marshall EE; Malouli D; Gilbride RM; Hughes CM; Ventura AB; Ainslie E; Randall KT; Selseth AN; Rundstrom P; Herlache L; Lewis MS; Park H; Planer SL; Turner JM; Fischer M; Armstrong C; Zweig RC; Valvo J; Braun JM; Shankar S; Lu L; Sylwester AW; Legasse AW; Messerle M; Jarvis MA; Amon LM; Aderem A; Alter G; Laddy DJ; Stone M; Bonavia A; Evans TG; Axthelm MK; Früh K; Edlefsen PT; Picker LJ
Nat Med; 2018 Feb; 24(2):130-143. PubMed ID: 29334373
[TBL] [Abstract][Full Text] [Related]
43. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
[TBL] [Abstract][Full Text] [Related]
44. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.
Goter-Robinson C; Derrick SC; Yang AL; Jeon BY; Morris SL
Vaccine; 2006 Apr; 24(17):3522-9. PubMed ID: 16519971
[TBL] [Abstract][Full Text] [Related]
45. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
46. Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.
Siddiqui KF; Amir M; Khan N; Rama Krishna G; Sheikh JA; Rajagopal K; Agrewala JN
Clin Exp Immunol; 2015 Aug; 181(2):286-96. PubMed ID: 25845290
[TBL] [Abstract][Full Text] [Related]
47. Diagnosis of latent tuberculosis infection in bacille Calmette-Guérin vaccinated subjects in China by interferon-gamma ELISpot assay.
Zhang M; Wang H; Liao M; Chen X; Graner M; Zhu X; Zhang J; Yang Q; Lu H; Zhou B; Chen X
Int J Tuberc Lung Dis; 2010 Dec; 14(12):1556-63. PubMed ID: 21144240
[TBL] [Abstract][Full Text] [Related]
48. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
49. Safety and Immunogenicity of Recombinant
Figl J; Köhler H; Wedlich N; Liebler-Tenorio EM; Grode L; Parzmair G; Krishnamoorthy G; Nieuwenhuizen NE; Kaufmann SHE; Menge C
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982586
[TBL] [Abstract][Full Text] [Related]
50. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
[TBL] [Abstract][Full Text] [Related]
51. Clofazimine enhances the efficacy of BCG revaccination via stem cell-like memory T cells.
Ahmad S; Bhattacharya D; Gupta N; Rawat V; Tousif S; Van Kaer L; Das G
PLoS Pathog; 2020 May; 16(5):e1008356. PubMed ID: 32437421
[TBL] [Abstract][Full Text] [Related]
52. High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation.
Sibley L; White AD; Gooch KE; Stevens LM; Tanner R; Jacobs A; Daykin-Pont O; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Pearson G; Rayner E; McShane H; Williams A; Dennis M; Marsh PD; Sharpe S
Sci Rep; 2021 Jun; 11(1):12274. PubMed ID: 34112845
[TBL] [Abstract][Full Text] [Related]
53. A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity.
Rai PK; Chodisetti SB; Zeng W; Nadeem S; Maurya SK; Pahari S; Janmeja AK; Jackson DC; Agrewala JN
J Transl Med; 2017 Oct; 15(1):201. PubMed ID: 28985739
[TBL] [Abstract][Full Text] [Related]
54. CHO expressed recombinant human lactoferrin as an adjuvant for BCG.
Hwang SA; Kruzel ML; Actor JK
Int J Immunopathol Pharmacol; 2015 Dec; 28(4):452-68. PubMed ID: 26315722
[TBL] [Abstract][Full Text] [Related]
55. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
Horvath CN; Xing Z
Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
[TBL] [Abstract][Full Text] [Related]
56. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
[TBL] [Abstract][Full Text] [Related]
57. BCG vaccination enhances resistance to M. tuberculosis infection in guinea pigs fed a low casein diet.
Sugawara I; Yamada H; Mizuno S
Tohoku J Exp Med; 2007 Mar; 211(3):259-68. PubMed ID: 17347551
[TBL] [Abstract][Full Text] [Related]
58. TB and SIV Coinfection; a Model for Evaluating Vaccine Strategies against TB Reactivation in Asian Origin Cynomolgus Macaques: A Pilot Study Using BCG Vaccination.
White AD; Sibley L; Gullick J; Sarfas C; Clark S; Fagrouch Z; Verschoor E; Salguero FJ; Dennis M; Sharpe S
Vaccines (Basel); 2021 Aug; 9(9):. PubMed ID: 34579182
[TBL] [Abstract][Full Text] [Related]
59. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
[TBL] [Abstract][Full Text] [Related]
60. Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A.
Tanner R; Kakalacheva K; Miller E; Pathan AA; Chalk R; Sander CR; Scriba T; Tameris M; Hawkridge T; Mahomed H; Hussey G; Hanekom W; Checkley A; McShane H; Fletcher HA
BMC Infect Dis; 2014 Dec; 14():660. PubMed ID: 25466778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
